Apple Forecasts Strong Revenue Growth as iPhone Demand Surges in China and India 
MAS Holds Monetary Policy Steady as Strong Growth Raises Inflation Risks 
Climate Adaptation at Home: How Irrigreen Makes Conservation Effortless 
Starmer’s China Visit Signals New Era in UK–China Economic Relations 
Indonesian Stocks Plunge as MSCI Downgrade Risk Sparks Investor Exodus 
Meta Stock Surges After Q4 2025 Earnings Beat and Strong Q1 2026 Revenue Outlook Despite Higher Capex 
Copper Prices Hit Record Highs as Metals Rally Gains Momentum on Geopolitical Tensions 
Dollar Struggles as Policy Uncertainty Weighs on Markets Despite Official Support 
American Airlines Plans Return to Venezuela Flights After U.S. Lifts Ban 
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs 
ASML’s EUV Lithography Machines Power Europe’s Most Valuable Tech Company 
Pentagon and Anthropic Clash Over AI Safeguards in National Security Use 
U.S. Dollar Slides for Second Week as Tariff Threats and Iran Tensions Shake Markets 
Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million 
Trump Threatens Aircraft Tariffs as U.S.-Canada Jet Certification Dispute Escalates 
Amazon Stock Dips as Reports Link Company to Potential $50B OpenAI Investment 
U.S. Stock Futures Edge Lower as Tech Earnings and Fed Decision Shape Market Sentiment 
Walmart announced on Tuesday, June 29, that it will start selling a cheaper version of the expensive insulin that most diabetic patients need to have regularly. The retailer unveiled the low-priced drug so that millions of Americans could have access to it even if they are on tight budgets.
Walmart’s intention for the release of inexpensive insulin
Walmart said that it priced the insulin in a manner that it could fit into the budgets of the patients, especially those who do not have any health insurance. The cheaper drug is also intended to help those who are struggling to pay for it.
Insulin is a lifesaving drug for diabetic people. Without it, many would suffer from various complications, and worse, it could also result in death since it is something that regulates glucose and carbohydrates in patients.
As per CNBC, starting this week, Walmart will be selling ReliOn NovoLog, an exclusive private-label version of analog insulin. This can be used by both adults and children as long as they have a prescription.
The price point of Walmart’s insulin drug
This insulin will be available for members of Sam’s Club starting in mid-July. It can be purchased for $73 per vial or around $86 for a pack of insulin pens. It was mentioned that Walmart previously sold $25 insulin, but doctors said the formulation is not effective in managing blood sugar, so it was upgraded and now coming to the retailer giant’s stores.
“This price point, we hope, will improve and hopefully revolutionize the accessibility and affordability of insulin,” Fox Business quoted Dr. Cheryl Pegus, Walmart’s executive vice president of health and wellness, as saying to the media in an interview. “We know that many people with diabetes struggle to manage this chronic condition because of its financial burden.”
Walmart’s ReliOn brand will release the FlexPen and insulin injection made by Novo Nordisk this week. Customers can purchase them from the retailer's pharmacy stores in the U.S.
Meanwhile, this is expected to help millions of people suffering from diabetes. It was reported that more than 34 million American citizens have diabetes and one in every four people are not aware that they have it, according to the Centers for Disease Control and Prevention (CDC).
